| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |